Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-09-26T00:15:56.818Z.
Consensus retrieved: 2026-09-13T23:23:47.232Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-09-26T00:15:56.818Z.
Quote observation: 2026-09-25T19:59:56.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 952443846e7129bc700ef7bf2084894d2617e14f8fd4d940df20fff97d2a629b
Forward PE Ratio (N/A) = Dated Quote Price ($190.79) / Consensus Forward EPS ($5.23)
FORWARD PE RATIO
N/A
Molina Healthcare, Inc.
Market Cap
$9.96B
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Molina Healthcare, Inc. (MOH) | $9.96B | N/A |
| Globus Medical, Inc. (GMED)vs › | $10.05B | 14.90 |
| Henry Schein, Inc. (HSIC)vs › | $9.84B | 16.04 |
| The Ensign Group, Inc. (ENSG)vs › | $10.21B | 22.48 |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $10.26B | 39.52 |
| Insulet Corp. (PODD)vs › | $9.43B | 20.93 |
| Align Technology, Inc. (ALGN)vs › | $10.51B | 13.00 |
| The Cooper Companies, Inc. (COO)vs › | $10.80B | 12.19 |
| Universal Health Services, Inc. (UHS)vs › | $10.83B | 7.94 |
| Bio-Techne Corporation (TECH)vs › | $11.37B | 35.33 |
Trailing P/E
1004.2
reported TTM EPS
Forward P/E
N/A
consensus EPS · fiscal year ending 2026-12-31
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $5.23 implies +2652.6% EPS growth vs the reported trailing $0.19.
At the dated quote price of $190.79, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $5.23 | $5.14 – $5.36 | 11 | 36.5x |
| 2027-12-31 | $9.72 | $8.96 – $10.95 | 6 | 19.6x |
| 2028-12-31 | $13.55 | $11.08 – $15.22 | 4 | 14.1x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
